Stage 1B Process Scale-Up Considerations
Processes ready for commercialization post Stage 1A need to demonstrate capability for commercial scaling. Commercial scale-up studies are conducted as part of Stage 1B process design activities. The manufacturing process is evaluated to estimate effect of scale. Product control strategy is optimized post Stage 1B studies. The successful completion of the stage ensures readiness for process performance qualification.
KeywordsScale-up Process design Critical process parameter Stage 1A Manufacturing process
- 2.SAS. Statistics for FDA process validation using JMP software, SAS. 2018.Google Scholar
- 3.Nayak BK, Elchidana P, Dixit M, Sahu PK. QbD approach: tablet compression process optimization using design of experiments. Int J Pharm Sci. 2016;38(2):45–53.Google Scholar
- 4.Pazhayattil A, Sayeed-Desta N, Iyer V. ICH Q12 post approval change management protocol: advantages for consumers, Regulators and Industry, RAPS. 2017.Google Scholar
- 5.US FDA. Guidance for Industry: Immediate release: solid oral dosage forms scale-up and post approval changes: chemistry, manufacturing, and controls, in vitro dissolution testing, and in vivo bioequivalence documentation, CDER, CMC. 1995.Google Scholar